BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34084001)

  • 1. Obstetric Antiphospholipid Syndrome: An Approach from Glycans of the Immunoglobulin G.
    Alvarez AM; Gomez-Gutierrez AM; Bueno-Sánchez JC; Rúa-Molina C; Cadavid AP
    J Hum Reprod Sci; 2021; 14(1):97-100. PubMed ID: 34084001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy.
    Rodríguez CM; Velásquez-Berrío M; Rúa C; Viana M; Abrahams VM; Cadavid AP; Alvarez AM
    Front Physiol; 2021; 12():706743. PubMed ID: 34912234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the activation of endothelial nitric oxide synthase and nitrosative stress biomarkers by aspirin triggered lipoxins: A possible mechanism of action of aspirin in the antiphospholipid syndrome.
    Granada-Gómez M; Velásquez-Berrío M; Molina CR; Martín SS; Escudero C; Alvarez AM; Cadavid AP
    Am J Reprod Immunol; 2023 Aug; 90(2):e13753. PubMed ID: 37491919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does seronegative obstetric APS exist? "pro" and "cons".
    Conti F; Andreoli L; Crisafulli F; Mancuso S; Truglia S; Tektonidou MG
    Autoimmun Rev; 2019 Dec; 18(12):102407. PubMed ID: 31639518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome.
    Ripoll VM; Pregnolato F; Mazza S; Bodio C; Grossi C; McDonnell T; Pericleous C; Meroni PL; Isenberg DA; Rahman A; Giles IP
    J Autoimmun; 2018 Sep; 93():114-123. PubMed ID: 30033000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion.
    Poulton K; Ripoll VM; Pericleous C; Meroni PL; Gerosa M; Ioannou Y; Rahman A; Giles IP
    Am J Reprod Immunol; 2015 May; 73(5):390-401. PubMed ID: 25469631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
    Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of antiphospholipid antibodies-induced trophoblast damage by different drugs used to prevent pregnancy morbidity associated with antiphospholipid syndrome.
    Alvarez AM; Balcázar N; San Martín S; Markert UR; Cadavid AP
    Am J Reprod Immunol; 2017 Apr; 77(4):. PubMed ID: 28132398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome.
    Velásquez M; Peláez LF; Rojas M; Narváez-Sánchez R; Velásquez JA; Escudero C; San Martín S; Cadavid ÁP
    Front Physiol; 2021; 12():764702. PubMed ID: 34925061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China.
    Zhou Z; Teng J; Sun Y; Liu H; Cheng X; Su Y; Yang C; Ye J
    Clin Rheumatol; 2019 Nov; 38(11):3161-3168. PubMed ID: 31290022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; LLurba E; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Espinosa G; de Carolis S; Rovere-Querini P; Lundelin K; Picardo E; Mekinian A;
    Med Clin (Barc); 2018 Sep; 151(6):215-222. PubMed ID: 29274674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome.
    Ferreira TG; Delhommeau F; Johanet C; Gerotziafas G; Bornes M; Cohen J; Kayem G; Fain O; Planche V; Mékinian A
    Clin Rheumatol; 2020 Apr; 39(4):1167-1171. PubMed ID: 31925628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases.
    Alijotas-Reig J; Ferrer-Oliveras R; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Coloma-Bazan E; de Carolis S; Espinosa G; Rovere-Querini P; Kuzenko A; Valverde EE; Robles A; Cervera R; Canti V; Fredi M; Gil-Aguado A; Lundelin K; Llurba E; Melnychuk T; Nalli C; Picardo E; Silvestro E; del Ross T; Farran-Codina I;
    Autoimmun Rev; 2015 May; 14(5):387-95. PubMed ID: 25555817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms of "Antiphospholipid Antibodies" and Their Paradoxical Role in the Pathogenesis of "Seronegative APS".
    Misasi R; Longo A; Recalchi S; Caissutti D; Riitano G; Manganelli V; Garofalo T; Sorice M; Capozzi A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
    Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome.
    Niznik S; Rapoport MJ; Avnery O; Lubetsky A; Shavit R; Ellis MH; Agmon-Levin N
    Front Pharmacol; 2022; 13():824775. PubMed ID: 35529433
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses.
    Radway-Bright EL; Ravirajan CT; Isenberg DA
    Rheumatology (Oxford); 2000 Apr; 39(4):427-31. PubMed ID: 10817777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.